Terms: = Breast cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Diagnosis
359 results:
1. Differentiation of invasive ductal and lobular carcinoma of the breast using MRI radiomic features: a pilot study.
Maiti S; Nayak S; Hebbar KD; Pendem S
F1000Res; 2024; 13():91. PubMed ID: 38571894
[TBL] [Abstract] [Full Text] [Related]
2. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
3. Metastatic profiles and survival differences between infiltrating ductal carcinoma and infiltrating lobular carcinoma in invasive breast cancer.
Cavaller L; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102740. PubMed ID: 38311000
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of Triple Negative breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
Yang X; Tang T; Zhou T
World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
[TBL] [Abstract] [Full Text] [Related]
6. Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study).
Antolín Novoa S; Escrivá-de-Romaní S; Tolosa Ortega P; Oliva Fernández L; López López R; López González A; de la Morena Barrio P; Echavarria Díaz-Guardamino I; Alés Martinez JE; Garate Z; González-Cortijo L
Cancer Treat Res Commun; 2023; 37():100772. PubMed ID: 37995519
[TBL] [Abstract] [Full Text] [Related]
7. Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma.
Yoon TI; Jeong J; Lee S; Ryu JM; Lee YJ; Lee JY; Hwang KT; Kim H; Kim S; Lee SB; Ko BS; Lee JW; Son BH; Metzger O; Kim HJ
JAMA Netw Open; 2023 Nov; 6(11):e2342270. PubMed ID: 37938845
[TBL] [Abstract] [Full Text] [Related]
8. Nonlobular Invasive breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Derakhshan F; Da Cruz Paula A; Selenica P; da Silva EM; Grabenstetter A; Jalali S; Gazzo AM; Dopeso H; Marra A; Brown DN; Ross DS; Mandelker D; Razavi P; Chandarlapaty S; Wen HY; Brogi E; Zhang H; Weigelt B; Pareja F; Reis-Filho JS
Mod Pathol; 2024 Feb; 37(2):100375. PubMed ID: 37925055
[TBL] [Abstract] [Full Text] [Related]
9. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract] [Full Text] [Related]
10. Investigation of the miR-637 and miR-523-5p as candidate biomarkers in breast cancer.
Coskunpinar E; Tiryakioglu DZ; Abaci N; Tukenmez M; Pence S
Bratisl Lek Listy; 2023; 124(11):814-820. PubMed ID: 37874803
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of breast cytoarchitecture and its associated axillary lymph node status under normal and pathological conditions in Egyptian women.
Mansour O; Kazem A; El Wakil A
Tissue Cell; 2023 Dec; 85():102244. PubMed ID: 37856936
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and Imaging Features of MRI Screen-Detected breast cancer.
Ghuman N; Ambinder EB; Oluyemi ET; Sutton E; Myers KS
Clin Breast Cancer; 2024 Jan; 24(1):45-52. PubMed ID: 37821332
[TBL] [Abstract] [Full Text] [Related]
13. Metaplastic breast carcinoma: Analysis of clinical and pathologic features, a five-year study.
Chaudhary D; Balhara K; Mandal S; Mallya V; Tomar R; Khurana N; Bains L
J Cancer Res Ther; 2023; 19(5):1226-1230. PubMed ID: 37787287
[TBL] [Abstract] [Full Text] [Related]
14. Unveiling bone metastasis: Exploring histological subtypes of breast cancer in Indonesia's tertiary referral hospital.
Siregar KB; Al Anas M
Cancer Treat Res Commun; 2023; 37():100764. PubMed ID: 37769530
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of coexisting invasive carcinoma on ductal carcinoma in situ (DCIS) lesions by mass spectrometry imaging.
Chen H; Li X; Li F; Li Y; Chen F; Zhang L; Ye F; Gong M; Bu H
J Pathol; 2023 Oct; 261(2):125-138. PubMed ID: 37555360
[TBL] [Abstract] [Full Text] [Related]
16. Fiber optic probe-based ATR-FTIR spectroscopy for rapid breast cancer detection: A pilot study.
Zhang S; Vasudevan S; Tan SPH; Olivo M
J Biophotonics; 2023 Nov; 16(11):e202300199. PubMed ID: 37496212
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ.
Liu Y; Yu T
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11181-11191. PubMed ID: 37354223
[TBL] [Abstract] [Full Text] [Related]
18. Metabolome Sequencing Reveals that Protein Arginine-N-Methyltransferase 1 Promotes the Progression of Invasive Micropapillary Carcinoma of the breast and Predicts a Poor Prognosis.
Wu K; Li W; Liu H; Niu C; Shi Q; Zhang J; Gao G; Sun H; Liu F; Fu L
Am J Pathol; 2023 Sep; 193(9):1267-1283. PubMed ID: 37301537
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence of BRCA1 and BRCA2 Mutations Among High-risk Bahraini Patients with breast cancer.
Bukamal Z; AlRayes A
Gulf J Oncolog; 2023 May; 1(42):22-25. PubMed ID: 37283256
[TBL] [Abstract] [Full Text] [Related]
20. Recurrence Network Analysis of Histopathological Images for the Detection of Invasive Ductal Carcinoma in breast cancer.
Chen CB; Wang Y; Fu X; Yang H
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(5):3234-3244. PubMed ID: 37276118
[TBL] [Abstract] [Full Text] [Related]
[Next]
